Zobrazeno 1 - 10
of 38
pro vyhledávání: '"M.A. Afanasyeva"'
Publikováno v:
Vestnik oftalmologii. 138(4)
To evaluate the effectiveness of anti-angiogenic therapy using fluctuation and variability in patients with exudative age-related macular degeneration (AMD).This study included 200 patients with types 1, 2, 3 neovascularization and polypoidal choroid
Publikováno v:
Modern technologies in ophtalmology. :296-300
Purpose. To study the primary response to anti-VEGF therapy with Aflibercept in patients with aneurysmal type 1 neovascularization (AN type 1). Material and methods. 11 patients with type I AN were examined. All patients underwent a standard ophthalm
Publikováno v:
Modern technologies in ophtalmology. :355-359
Retinal angiomatous proliferation (RAP) is a separate form of neovascular age-related macular degeneration (nAMD), which accounts for 12-15% of newly diagnosed patients with nAMD [14]. It is believed that the development of RAP is associated with vas
Publikováno v:
Environmental Protection in Oil and Gas Complex. :22-27
Publikováno v:
Vestnik oftalmologii. 137(5)
The neovascular form of age-related macular degeneration (AMD) is characterized by growth of newly formed vessels, accumulation of fluid and, in most cases, presence of retinal pigment epithelium detachment. Depending on its localization in relation
Autor:
A.A. Plyukhova, M.A. Afanasyeva
Publikováno v:
POINT OF VIEW. EAST – WEST. :40-42
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Modern technologies in ophtalmology. :87-88
Autor:
M.A. Afanasyeva
Publikováno v:
SCIENTIFIC DEVELOPMENT TRENDS AND EDUCATION. 53
Autor:
M.V. Budzinskaya, M.A. Afanasyeva, A.A. Plyukhova, I.A. Novikov, A.V. Shelankova, I.V. Andreeva
Publikováno v:
Vestnik oftal'mologii. 138:12
To assess the effectiveness of anti-VEGF therapy in different types of fluids localization in neovascular age-related macular degeneration (AMD).The study included 16 people (16 eyes) with exudative AMD. The study included patients with fibrovascular